A neuroprotective effect of newly isolated probiotic bacterium Lactobacillus acidophilus SLAM_LAA02 in a rotenone-induced mouse model of Parkinson’s disease
The gut microbiota plays a pivotal role in maintaining host health and has increasingly been linked to the pathogenesis of neurodegenerative diseases through the microbiota-gut-brain axis. Parkinson's disease (PD), characterized by dopaminergic dysfunction, neuro inflammation, and pathological alpha-synuclein (α-synuclein) aggregation, is frequently accompanied by gut microbial dysbiosis. Probiotics isolated from human infants could offer distinct neuroprotective and immunomodulatory benefits, yet their effects on integrated gut-brain axis models remain underexplored. In this study, we investigated the therapeutic potential of Lactobacillus acidophilus SLAM_LAA02 (L. acidophilus SLAM_LAA02), a novel infant-derived strain, in modulating PD-related behavioral and neuropathological features via modulation of the gut-brain axis. Following comprehensive safety and functional assessments, we first assessed L. acidophilus SLAM_LAA02 in Caenorhabditis elegans, where supplementation extended lifespan, enhanced antimicrobial defense, improved behavioral responses, and reduced α-synuclein expression in transgenic worms. We then evaluated its effects in a rotenone-induced mouse model that reflects early-stage PD-like features. L. acidophilus SLAM_LAA02 administration ameliorated motor dysfunction, modulated neuroinflammatory signaling, restored gut microbial diversity, and improved intestinal barrier-associated outcomes. These changes were accompanied by a notable reduction in α-synuclein expression and upregulated neuroprotective gene expression, including brain-derived neurotrophic factor (BDNF). Together, these findings suggest that L. acidophilus SLAM_LAA02 exhibits neuroprotective and gut-modulating properties across complementary model systems, supporting its potential as a promising probiotic candidate for alleviating early PD-related dysfunctions through the gut-brain axis.
Authors
- Anna Kang (ORCID: https://orcid.org/0000-0003-0208-6234)
- Sangnam Oh (ORCID: https://orcid.org/0000-0002-2428-412X)
- Young-Hoon Kim (ORCID: https://orcid.org/0000-0003-4656-0188)
- Yeon Soo Kim (ORCID: https://orcid.org/0000-0003-1447-0196)
- Eunsol Seo (ORCID: https://orcid.org/0000-0003-3589-6081)
- Min-Geun Kang (ORCID: https://orcid.org/0000-0002-2204-6443)
- Ki Chang Jang
Institutions
- Seoul National University (KR)
- National University College (PR)
- Jeonju University (KR)
Publication Details
- Journal
- Biomedicine & Pharmacotherapy
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1016/j.biopha.2025.118896
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00